Clinical Trials Directory

Trials / Completed

CompletedNCT00345150

Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls

Phase 1 Study of the Effects of Systemic Nitric Oxide Inhibition With Ng-Monomethyl-L-Arginine on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (planned)
Sponsor
Regional Hospital Holstebro · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

The study tests the hypothesis that systemic and renal nitric oxide synthesis is changed in essential hypertension by investigating the effects of a non selective nitric oxide inhibitor on renal hemodynamics and sodium excretion in patients with essential hypertension. The results are compared with a group of healthy subjects.

Detailed description

The study investigates the effects of Ng-monomethyl-L-arginine (L-NMMA) on: 1. renal hemodynamics (renal plasma flow and glomerular filtration rate) 2. renal sodium excretion 3. lithium clearance and fractional lithium excretion 4. plasma levels of vasoactive hormones 5. blood pressure and heart rate

Conditions

Interventions

TypeNameDescription
DRUGNg-monomethyl-L-arginine (drug)

Timeline

First posted
2006-06-27
Last updated
2006-06-27

Source: ClinicalTrials.gov record NCT00345150. Inclusion in this directory is not an endorsement.